Citadel Advisors’s SEQUENOM INC NEW SQNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-3,900
Closed -$6K 8939
2015
Q4
$6K Sell
3,900
-900
-19% -$1.54K ﹤0.01% 8434
2015
Q3
$8K Sell
4,800
-6,100
-56% -$14.9K ﹤0.01% 8553
2015
Q2
$33K Sell
10,900
-6,100
-36% -$23K ﹤0.01% 7912
2015
Q1
$67K Sell
17,000
-45,700
-73% -$168K ﹤0.01% 7183
2014
Q4
$232K Buy
62,700
+18,900
+43% +$61.2K ﹤0.01% 5801
2014
Q3
$130K Buy
43,800
+5,300
+14% +$19.4K ﹤0.01% 6165
2014
Q2
$149K Sell
38,500
-5,000
-11% -$14.6K ﹤0.01% 5880
2014
Q1
$107K Sell
43,500
-37,200
-46% -$88.7K ﹤0.01% 6134
2013
Q4
$189K Sell
80,700
-54,200
-40% -$129K ﹤0.01% 5085
2013
Q3
$360K Sell
134,900
-17,200
-11% -$57.8K ﹤0.01% 4164
2013
Q2
$640K Buy
+152,100
New +$609K ﹤0.01% 3607

Citadel Advisors's SQNM Position: Q3 2016 in Review

Citadel Advisors sold out of SEQUENOM INC NEW (SQNM) in Q3 2016, closing a stake of 12,870 shares — an estimated $12K sold.

Citadel Advisors first reported a position in SQNM in Q2 2013 and held it in 10 quarters. The position peaked at $658K in Q2 2014. 0 funds tracked by Wall St. Rank hold SQNM as of Q3 2016.

  • Citadel Advisors reported no remaining SEQUENOM INC NEW position as of Q3 2016 after selling out during the quarter.
  • Citadel Advisors sold 12,870 SEQUENOM INC NEW shares in Q3 2016, an estimated $12K.
  • Citadel Advisors first reported a position in SEQUENOM INC NEW in Q2 2013 and held it in 10 quarters.
  • Citadel Advisors's SEQUENOM INC NEW position peaked at $658K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q3 2016.

Based on Citadel Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.